How can a public biofoundry develop and demonstrate capabilities that enable commercially-relevant biomanufacturing of a wide range of bioproducts by both new and established industrial hosts? The ABF has operated as a BETO-supported project since 2016. In 2017 the ABF expanded to a $20M/year BETO-consortium. The goal? To enable biorefineries to achieve 50% reductions in time to bioprocess scale-up as compared to the current average of around 10 years by establishing a distributed Agile BioFoundry to productionize synthetic biology. For the overview, Nathan J. Hillson pf Berkeley Lab  presented these slides at DOE Project Peer Review.